Phenotypes, mechanisms and therapeutics: insights from bipolar disorder GWAS findings
- 29 March 2022
- journal article
- review article
- Published by Springer Nature in Molecular Psychiatry
- Vol. 27 (7) , 2927-2939
Abstract
Genome-wide association studies (GWAS) have reported substantial genomic loci significantly associated with clinical risk of bipolar disorder (BD), and studies combining techniques of genetics, neuroscience, neuroimaging, and pharmacology are believed to help tackle clinical problems (e.g., identifying novel therapeutic targets). However, translating findings of psychiatric genetics into biological mechanisms underlying BD pathogenesis remains less successful. Biological impacts of majority of BD GWAS risk loci are obscure, and the involvement of many GWAS risk genes in this illness is yet to be investigated. It is thus necessary to review the progress of applying BD GWAS risk genes in the research and intervention of the disorder. A comprehensive literature search found that a number of such risk genes had been investigated in cellular or animal models, even before they were highlighted in BD GWAS. Intriguingly, manipulation of many BD risk genes (e.g., ANK3, CACNA1C, CACNA1B, HOMER1, KCNB1, MCHR1, NCAN, SHANK2 etc.) resulted in altered murine behaviors largely restoring BD clinical manifestations, including mania-like symptoms such as hyperactivity, anxiolytic-like behavior, as well as antidepressant-like behavior, and these abnormalities could be attenuated by mood stabilizers. In addition to recapitulating phenotypic characteristics of BD, some GWAS risk genes further provided clues for the neurobiology of this illness, such as aberrant activation and functional connectivity of brain areas in the limbic system, and modulated dendritic spine morphogenesis as well as synaptic plasticity and transmission. Therefore, BD GWAS risk genes are undoubtedly pivotal resources for modeling this illness, and might be translational therapeutic targets in the future clinical management of BD. We discuss both promising prospects and cautions in utilizing the bulk of useful resources generated by GWAS studies. Systematic integrations of findings from genetic and neuroscience studies are called for to promote our understanding and intervention of BD.Keywords
This publication has 198 references indexed in Scilit:
- Genome-wide significant association between a ‘negative mood delusions’ dimension in bipolar disorder and genetic variation on chromosome 3q26.1Translational Psychiatry, 2012
- Forebrain elimination of cacna1c mediates anxiety-like behavior in miceMolecular Psychiatry, 2012
- Amygdala Hyperactivation During Face Emotion Processing in Unaffected Youth at Risk for Bipolar DisorderJournal of the American Academy of Child & Adolescent Psychiatry, 2012
- Genome-wide Association Study Identifies Genetic Variation in Neurocan as a Susceptibility Factor for Bipolar DisorderThe American Journal of Human Genetics, 2011
- Dendritic spine pathology in neuropsychiatric disordersNature Neuroscience, 2011
- Mood Disorder Susceptibility Gene CACNA1C Modifies Mood-Related Behaviors in Mice and Interacts with Sex to Influence Behavior in Mice and Diagnosis in HumansBiological Psychiatry, 2010
- Genetic Variation in CACNA1C Affects Brain Circuitries Related to Mental IllnessArchives of General Psychiatry, 2010
- Elevated Amygdala Activity to Sad Facial Expressions: A State Marker of Bipolar but Not Unipolar DepressionBiological Psychiatry, 2010
- Neurocognitive Endophenotypes for Bipolar Disorder Identified in Multiplex Multigenerational FamiliesArchives of General Psychiatry, 2010
- Differential Association of Circadian Genes with Mood Disorders: CRY1 and NPAS2 are Associated with Unipolar Major Depression and CLOCK and VIP with Bipolar DisorderNeuropsychopharmacology, 2010